A subarachnoid stroke is a cerebrovascular disorder caused by a disruption of blood flow to the brain. It can be a life-threatening condition and is primarily caused by a subarachnoid hemorrhage, which is bleeding inside and around the brain. It occurs when an aneurysm (abnormal ballooning of a blood vessel wall) or arteriovenous malformation (AVM, an abnormally-formed blood vessel connection between an artery and vein) ruptures in the brain. The resulting bleeding into the subarachnoid space (space between the brain and the skull) leads to rapid decompression of the brain, resulting in a stroke. Subarachnoid strokes usually present with sudden, severe headaches, along with other symptoms such as nausea, vomiting, rigid neck, drowsiness, confusion, and seizures. A computed tomography (CT) scan or magnetic resonance imaging (MRI) is used to diagnose the condition. Treatment for subarachnoid stroke can involve, repairing the ruptured blood vessel, controlling intracranial pressure, stabilizing vital signs, and managing complications such as seizures. In some cases, doctors may recommend surgical intervention to repair the affected blood vessels. Preventative measures for subarachnoid stroke include controlling risk factors such as high blood pressure, avoiding smoking, and maintaining a healthy diet and lifestyle. It is also important to be aware of warning signs and to seek medical help immediately if signs and symptoms of a subarachnoid stroke arise. With prompt treatment, the prognosis for a subarachnoid stroke is usually good, with the majority of patients making a full recovery
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom